Raymond James Financial Services Advisors’s Firefly Neuroscience AIFF Stock Holding History

Raymond James Financial Services Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-650	Closed	-$5.04K	–	3443
2023 Q3	$5.04K	Hold	650	–	–	﹤0.01%	3247
2023 Q2	$5.95K	Hold	650	–	–	﹤0.01%	3222
2023 Q1	$5.64K	Hold	650	–	–	﹤0.01%	3239
2022 Q4	$9.36K	Hold	650	–	–	﹤0.01%	3197
2022 Q3	$19K	Hold	650	–	–	﹤0.01%	3166
2022 Q2	$26K	Buy	+650	New	+$62.7K	﹤0.01%	3143

Other funds holding AIFF

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

TWM

Trueblood Wealth Management Lima, Ohio $286M AUM 27.34% 1-Year Est. Return

Lafayette Investments Ashton, Maryland $542M AUM 22.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WPW

Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial Services Advisors's AIFF Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of Firefly Neuroscience (AIFF) in Q4 2023, closing a stake of 650 shares — an estimated $5.04K sold.

Raymond James Financial Services Advisors first reported a position in AIFF in Q2 2022 and held it in 6 quarters. The position peaked at $26K in Q2 2022. 10 funds tracked by Wall St. Rank hold AIFF as of Q4 2023.

Raymond James Financial Services Advisors reported no remaining Firefly Neuroscience position as of Q4 2023 after selling out during the quarter.
Raymond James Financial Services Advisors sold 650 Firefly Neuroscience shares in Q4 2023, an estimated $5.04K.
Raymond James Financial Services Advisors first reported a position in Firefly Neuroscience in Q2 2022 and held it in 6 quarters.
Raymond James Financial Services Advisors's Firefly Neuroscience position peaked at $26K in Q2 2022.
10 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.